PIK3CA and breast neoplasm: Thus, Wnt pathway activation appears to be an important consequence of PIK3CA mutations in breast tumors, in keeping with recently observed crosstalk between the PI3K/Akt and Wnt pathways in both physiological (myeloid progenitor cells) [21] and pathological conditions (medulloblastoma) [34].